Lipid Bound Iodine Therapy for Broad Antibiotics Resistance
Lipid Bound Iodine - Antimicrobial Resistance Minimising Solution
Tags: Australian National University, Australia, Healthcare & Lifesciences
ANU researchers have developed a novel lipid-bound iodine therapy with broad antimicrobial activity, offering a potential solution to antibiotic resistance, one of the top global health threats. This innovation enables targeted delivery for treating various infections without causing iodine overload. It is versatile, showing promise in human and veterinary care, including treatments for urinary tract infections and as a broad-spectrum antiseptic. The technology is easy to use, stable, and cost-effective, suitable for widespread application in infection control and combating antibiotic resistance.
IP Type or Form Factor: Patent Pending; Platform; Material
TRL: 4 - minimum viable product built in lab
Industry or Tech Area: Public Health & Universal Healthcare; Pharmaceutical Engineering
